B · Normal
[State Food and Drug Administration: 27 batches of drugs from 17 pharmaceutical companies including Beijing Tongrentang did not meet regulations] On November 17, we learned from the State Food and Drug Administration that the latest drug sampling notice showed that after inspection by 7 drug inspection agencies including the Tianjin Institute for Drug Inspection, it was marked as Beijing 27 batches of drugs produced by 17 pharmaceutical companies including Beijing Tongrentang Co., Ltd. Tongrentang Pharmaceutical Factory did not meet the regulations. The water content of these 27 batches of drugs, the presence of visible foreign matter in the drugs, and the dissolution rate and degree of active drugs did not meet the requirements of Chinese pharmaceutical regulations. The State Food and Drug Administration stated that for these drugs found to be non-compliant during random inspections, the drug regulatory department has required relevant companies and units to take risk control measures such as suspending sales and use, recalling, etc., to investigate the reasons and make practical rectifications. At the same time, the relevant provincial drug regulatory authorities are required to initiate investigations into suspected illegal activities of relevant enterprises and units, and make the investigation results public in accordance with regulations.
🕐 2026-11-17 12:06

Comments

0/500
Captcha (click to refresh)
No comments yet